• Technology
    • First Access Challenge
    • Resources
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
    • Corporate Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact IR
  • Blog
  • Contact
Nautilus Biotechnology
  • Technology
    • First Access Challenge
    • Resources
  • Company
  • Collaborate
  • Careers
  • Investors
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • IR Resources
  • Blog
  • Contact

Next-generation proteomics technologies - Protein Identification by Short epitope Mapping (PrISM)

December 13, 2022
Jamie Rose Kuhar
LinkedIn

As we discussed in a previous post, proteins are the key determinants of cellular function. Recognizing this, scientists have been using and developing means to study proteins for many years. However, traditional methods of studying proteins cannot provide truly comprehensive data on the proteome, the full set of proteins in a sample with their associated abundances and locations. Even a relatively omics-scale method like mass spectroscopy can only measure a small fraction of the proteins in a cell. Accessing largely untapped, comprehensive proteomic data will enable scientists to better understand and manipulate cellular functions in health and disease. This will lead to better disease treatments and diagnostics in addition to high-yielding crops and novel means of protecting the environment.
 

Seeing this potential, many scientists have set out to create next-generation proteomics technologies. These technologies aim to deliver comprehensive data on the proteome from any sample of interest. Although many of these technologies are still in development, they should be available to researchers soon and will spur a proteomics revolution. In this series, we cover the concepts behind two kinds of next-generation proteomics technologies including:

 

  • Next-generation protein sequencing 
  • Protein Identification by Short epitope Mapping (PrISM) 

 

These posts are not intended to provide in-depth descriptions, but instead provide an overview of how these technologies work.  

 

In the graphics portraying the technologies below, we provide qualitative assessments of proteome coverage and ease-of-use. While technologies with low proteome coverage are generally used for targeted experiments looking at a small number of proteins at once, medium coverage technologies can look at 100s to 1000s of proteins at once. Truly comprehensive, high proteome coverage technologies can analyze tens of thousands of proteins at once. 

 

Low ease-of-use technologies generally require complicated, difficult, or customized sample preparation with a lot of hands-on experimenter time, and their data may be difficult to analyze or require bioinformatics support. High ease-of-use technologies employ simple, standardized sample preparation, include more automation, and provide simple, data-rich outputs. Medium ease-of-use technologies have some mix of these attributes. 

 

In addition to assessing standard metrics like these, we also discuss some of the pros and cons of each technology. Many of the pros and cons discussed below are specific to the capabilities of the technology. 

 

Importantly, the technology assessments here should not be viewed as definitive. Rather, they aim to help you think about how you can best leverage these technologies for your experimental goals. 

 

In a previous post, we covered Next-generation protein sequencing. Today we cover Protein Identification by Short epitope Mapping (PrISM), the theoretical framework underpinning the Nautilus platform. For more in-depth information on next-generation proteomics technologies see Alfaro et al 2021 and Timp and Timp 2020.

Protein Identification by Short epitope Mapping (PrISM)

Graphic describing how the theoretical framework underpinning the Nautilus proteomics platform, Protein Identification by Short epitope Mapping (PrISM), works. The graphic reads: PrISM repeatedly interrogate billions of single, intact protein molecules with a diverse array of novel affinity reagents. Machine learning algorithms decode the binding patterns generated during each cycle to identify the proteins and quantity is simply determined by counts.

 

With the founding of Nautilus, we set out to develop a technology that could deliver a simple but information-rich readout of the abundance of tens of thousands of proteins from just about any sample of interest with minimal sample prep and hands-on time. The theoretical framework underpinning our platform is called Protein Identification by Short epitope Mapping (PrISM). With this technique, rather than use highly specific affinity reagents that bind to individual proteins, we make use of novel affinity reagents that bind to short sequences of amino acids with high affinity and low specificity. These probes stochastically bind to many different proteins. If one were to add just a few of them to a sample and monitor binding, they would not identify any individual proteins with confidence. Instead, with PrISM, we monitor how hundreds of these multi-affinity probes bind to individual proteins at the single-molecule level. This generates binding patterns for each protein molecule and then the patterns can be decoded by machine learning algorithms to determine the identity of each protein molecule. 

 

Alongside these multi-affinity probes, we have developed nano-fabricated chips with billions of landing pads for single-protein molecules. With standardized preparation techniques, researchers can prepare their samples for automated loading onto the chips where individual proteins bind to each landing pad. We have also developed instrumentation that can monitor multi-affinity probe binding at each individual landing pad. Thus, with our platform, we can flow hundreds of our multi-affinity probes over the chip sequentially and monitor binding patterns for each protein at the single-molecule level. The platform then uses machine learning algorithms to identify the proteins found at each landing pad following the PrISM framework. Because proteins are identified at the single-molecule level, we can quantify proteins in a sample by adding up identified proteins of the same species. The researcher gets a simple list of protein identities and their abundances. 

 

Pros and cons of PrISM

Pros 

 

  • Comprehensive proteome coverage – By isolating and repeatedly interrogating billions of single, intact protein molecules with a diverse array of multi-affinity probes that overcome the challenges of single-reagent sensitivity and specificity, PrISM can achieve scale matching that of the proteome. 

 

  • Sensitivity – Single-molecule sensitivity enables PrISM to measure low abundance proteins and proteoforms with precision.
     
  • Ease-of-use – A simple workflow from sample preparation to data analysis reduces time from sample to data. Researchers get a simple but information-rich list of protein counts and therefore protein quantities. 

 

Cons
 

  • Novel protein identification is challenging – Although the binding patterns identified by PrISM can be predicted from known protein sequences, PrISM cannot yet identify novel proteins. This may be possible in the future.
     

See our recent bioRxiv pre-prints for more information on our affinity reagents, the framework for Protein Identification by Short Epitope Mapping (PrISM), and the development of our single-molecule protein arrays. 

 

The proteomics revolution is upon us 

The next-generation technologies described in this series can help to drive the proteomics revolution. When these technologies are widely available, researchers will hopefully use them to make breakthroughs in basic research, healthcare, agriculture, and more! 

Browse by topic

  • Nautilus in the News
  • Events
  • Research and collaborations
  • Nautilus and our Platform
  • Proteomics
  • Life at Nautilus
  • Industry Interviews
SUBSCRIBE
Back To Blog

Nautilus Biotechnology

 

Corporate Headquarters
2701 Eastlake Avenue East
Seattle, WA 98102

 

Research Headquarters
835 Industrial Road, Suite 200
San Carlos, CA 94070

 

     

+1 (206) 333-2001

© 2022 Nautilus Biotechnology Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

We use cookies in order to continually improve your experience on our website. By clicking “Accept cookies” or clicking on any content on our site, you are consenting to our use of cookies as described in our Privacy Policy. You can opt-out if you wish. Accept Reject All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT